Insulin resistance does not diminish eNOS expression, phosphorylation, or binding to HSP-90

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 287, Issue 6 56-6, 2004, Pages

  Fulton, David ^a   Harris, M Brennan ^a   Kemp, Bruce E ^b   Venema, Richard C ^a   Marrero, Mario B ^a   Stepp, David W ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Obesity; Syndrome X; Zucker

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; HEAT SHOCK PROTEIN 90; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; INSULIN RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; RAT; SYNDROME X; VASCULAR ENDOTHELIUM;

ANIMALS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HSP90 HEAT-SHOCK PROTEINS; INSULIN RESISTANCE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; RATS, ZUCKER; RNA, MESSENGER; VASODILATION;

EID: 9344236577     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00280.2004     Document Type: Article

References (53)

1. Balletshofer BM, Rittig K, Enderle MD, Volk A, Maerker E, Jacob S, Matthaei S, Rett K, and Haring HU. Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance. Circulation 101: 1780-1784, 2000.
2. 635 produces NO without requiring intracellular calcium increase. Free Radic Biol Med 35: 729-741, 2003.
3. Bray GA. The Zucker-fatty rat: a review. Fed Proc 36: 148-153, 1977.
4. Byon JC, Kusari AB, and Kusari J. Protein-tyrosine phosphatase-1B acts as a negative regulator of insulin signal transduction. Mol Cell Biochem 182: 101-108, 1998.
5. Crouse JA, Elliott GE, Burgess TL, Chiu L, Bennett L, Moore J, Nicolson M, and Pacifici RE. Altered cell surface expression and signaling of leptin receptors containing the fatty mutation. J Biol Chem 273: 18365-18373, 1998.
6. Ding Y, Vaziri ND, Coulson R, Kamanna VS, and Roh DD. Effects of simulated hyperglycemia, insulin, and glucagon on endothelial nitric oxide synthase expression. Am J Physiol Endocrinol Metab 279: E11-E17, 2000.
7. Duplain H, Burcelin R, Sartori C, Cook S, Egli M, Lepori M, Vollenweider P, Pedrazzini T, Nicod P, Thorens B, and Scherrer U. Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation 104: 342-345, 2001.
8. Federici M, Menghini R, Mauriello A, Hribal ML, Ferrelli F, Lauro D, Sbraccia P, Spagnoli LG, Sesti G, and Lauro R. Insulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endothelial cells. Circulation 106: 466-472, 2002.
9. Federici M, Pandolfi A, De Filippis EA, Pellegrini G, Menghini R, Lauro D, Cardellini M, Romano M, Sesti G, Lauro R, and Consoli A. G972R IRS-1 variant impairs insulin regulation of endothelial nitric oxide synthase in cultured human endothelial cells. Circulation 109: 399-405, 2004.
10. Felaco M, Di Maio FD, De Fazio P, D'Arcangelo C, De Lutiis MA, Varvara G, Grilli A, Barbacane RC, Reale M, and Conti P. Localization of the e-NOS enzyme in endothelial cells and odontoblasts of healthy human dental pulp. Life Sci 68: 297-306, 2000.
11. Fleming I and Busse R. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol 284: R1-R12, 2003.
12. 2+/calmodulin- dependent endothelial nitric oxide synthase activity. Circ Res 88: E68-E75, 2001.
13. Fontana J, Fulton D, Chen Y, Fairchild TA, McCabe TJ, Fujita N, Tsuruo T, and Sessa WC. Domain mapping studies reveal that the M domain of hsp90 serves as a molecular scaffold to regulate Akt-dependent phosphorylation of endothelial nitric oxide synthase and NO release. Circ Res 90: 866-873, 2002.
14. Frisbee JC and Stepp DW. Impaired NO-dependent dilation of skeletal muscle arterioles in hypertensive diabetic obese Zucker rats. Am J Physiol Heart Circ Physiol 281 : H1304-H1311, 2001.
15. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, and Sessa WC. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399: 597-601, 1999.
16. Fulton D, Gratton JP, and Sessa WC. Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough? J Pharmacol Exp Ther 299: 818-824, 2001.
17. Garcia-Cardena G, Fan R, Shah V, Sorrentino R, Cirino G, Papapetropoulos A, and Sessa WC. Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature 392: 821-824, 1998.
18. Harris MB, Ju H, Venema VJ, Liang H, Zou R, Michell BJ, Chen ZP, Kemp BE, and Venema RC. Reciprocal phosphorylation and regulation of endothelial nitric-oxide synthase in response to bradykinin stimulation. J Biol Chem 276: 16587-16591, 2001.
19. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, and Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 95: 2509-2514, 1998.
20. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, and Fishman MC. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377: 239-242, 1995.
21. Ignarro LJ, Buga GM, Wood, KS, Byrns RE, and Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84: 9265-9269, 1987.
22. Johnson PR, Greenwood MR, Horwitz BA, and Stern JS. Animal models of obesity: genetic aspects. Annu Rev Nutr 11: 325-353, 1991.
23. Jungersten L, Edlund A, Petersson AS, and Wennmalm A. Plasma nitrate as an index of nitric oxide formation in man: analyses of kinetics and confounding factors. Clin Physiol 16: 369-379, 1996.
24. Kasiske BL, O'Donnell MP, and Keane WF. The Zucker rat model of obesity, insulin resistance, hyperlipidemia, and renal injury. Hypertension 19: 1110-1115, 1992.
25. Katakam PV, Ujhelyi MR, Hoenig ME, and Miller AW. Endothelial dysfunction precedes hypertension in diet-induced insulin resistance. Am J Physiol Regul Integr Comp Physiol 275: R788-R792, 1998.
26. Keller KB and Lemberg L. Obesity and the metabolic syndrome. Am J Crit Care 12: 167-170, 2003.
27. Koshinaka K, Oshida Y, Han YQ, Ohsawa I, and Sato Y. The effect of nitric oxide synthase inhibitor on improved insulin action by pioglitazone in high-fructose-fed rats. Metabolism 53: 22-27, 2004.
28. Kuboki K, Jiang ZY, Takahara N, Ha SW, Igarashi M, Yamauchi T, Feener EP, Herbert TP, Rhodes CJ, and King GL. Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin. Circulation 101: 676-681, 2000.
29. Lin MI, Fulton D, Babbitt R, Flemming I, Busse R, Pritchard KA Jr, and Sessa WC. Phosphorylation of threonine 497 in endothelial nitric oxide synthase coordinates the coupling of L-arginine metabolism to efficient nitric oxide production. J Biol Chem 278: 44719-44726, 2003.
30. Meigs JB. Epidemiology of the insulin resistance syndrome. Curr Diab Rep 3: 73-79, 2003.
31. Miatello R, Risler N, Castro C, Gonzalez S, Ruttler M, and Cruzado M. Aortic smooth muscle cell proliferation and endothelial nitric oxide synthase activity in fructose-fed rats. Am J Hypertens 14: 1135-1141, 2001.
32. Michell BJ, Harris MB, Chen ZP, Ju H, Venema VJ, Blackstone MA, Huang W, Venema RC, and Kemp BE. Identification of regulatory sites of phosphorylation of the bovine endothelial nitric-oxide synthase at serine 617 and serine 635. J Biol Chem 277: 42344-42351, 2002.
33. Miller AW, Sims JJ, Canavan A, Hsu T, and Ujhelyi MR. Impaired vagal reflex activity in insulin-resistant rats. J Cardiovasc Pharmacol 33: 698-702, 1999.
34. Okon EB, Szado T, Laher I, McManus B, and van Breemen C. Augmented contractile response of vascular smooth muscle in a diabetic mouse model. J Vasc Res 40: 520-530, 2003.
35. Palmer RM, Ferrige AG, and Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-526, 1987.
36. Pritchard KA, Ackerman AW, Ou J, Curtis M, Smalley DM, Fontana JT, Stemerman MB, and Sessa WC. Native low-density lipoprotein induces endothelial nitric oxide synthase dysfunction: role of heat shock protein 90 and caveolin-1. Free Radic Biol Med 33: 52-62, 2002.
37. Pritchard KA Jr, Ackerman AW, Gross ER, Stepp DW, Shi Y, Fontana JT, Baker JE, and Sessa WC. Heat shock protein 90 mediates the balance of nitric oxide and Superoxide anion from endothelial nitric-oxide synthase. J Biol Chem 276: 17621-17624, 2001.
38. 1177 phosphorylation in human aortic endothelial cells. J Biol Chem 278: 18791-18797, 2003.
39. Scherrer U, Randin D, Vollenweider P, Vollenweider L, and Nicod P. Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest 94: 2511-2515, 1994.
40. Schwaninger RM, Sun H, and Mayhan WG. Impaired nitric oxide synthase-dependent dilatation of cerebral arterioles in type II diabetic rats. Life Sci 73: 3415-3425, 2003.
41. Shankar RR, Wu Y, Shen HQ, Zhu JS, and Baron AD. Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance. Diabetes 49: 684-687, 2000.
42. - imbalance in insulin-resistant rat aorta. Diabetes 48: 2437-2445, 1999.
43. Singleton JR, Smith AG, Russell JW, and Feldman EL. Microvascular complications of impaired glucose tolerance. Diabetes 52: 2867-2873, 2003.
44. Sowers JR, Epstein M, and Frohlich ED. Diabetes, hypertension, and cardiovascular disease: an update. Hypertension 37: 1053-1059, 2001.
45. Stalker TJ, Skvarka CB, and Scalia R. A novel role for calpains in the endothelial dysfunction of hyperglycemia. FASEB J 17: 1511-1513, 2003.
46. Steinberg HO, Brechtel G, Johnson A, Fineberg N, and Baron AD. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest 94: 1172-1179, 1994.
47. Strojek K. Features of macrovascular complications in type 2 diabetic patients. Acta Diabetol 40 Suppl 2: S334-S337, 2003.
48. Takaya K, Ogawa Y, Isse N, Okazaki T, Satoh N, Masuzaki H, Mori K, Tamura N, Hosoda K, and Nakao K. Molecular cloning of rat leptin receptor isoform complementary DNAs-identification of a missense mutation in Zucker fatty (fa/fa) rats. Biochem Biophys Res Commun 225: 75-83, 1996.
49. Verma S, Bhanot S, Yao L, and McNeill JH. Defective endothelium-dependent relaxation in fructose-hypertensive rats. Am J Hypertens 9: 370-376, 1996.
50. Vicent D, Ilany J, Kondo T, Naruse K, Fisher SJ, Kisanuki YY, Bursell S, Yanagisawa M, King GL, and Kahn CR. The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance. J Clin Invest 111: 1373-1380, 2003.
51. Walchli S, Curchod ML, Gobert RP, Arkinstall S, and Hooft van Huijsduijnen R. Identification of tyrosine phosphatases that dephosphorylate the insulin receptor. A brute force approach based on "substrate- trapping" mutants. J Biol Chem 275: 9792-9796, 2000.
52. Watson KE, Peters Harmel AL, and Matson G. Atherosclerosis in type 2 diabetes mellitus: the role of insulin resistance. J Cardiovasc Pharmacol Ther 8: 253-260, 2003.
53. Zeballos GA, Bernstein RD, Thompson CI, Forfia PR, Seyedi N, Shen W, Kaminiski PM, Wolin MS, and Hintze TH. Pharmacodynamics of plasma nitrate/nitrite as an indication of nitric oxide formation in conscious dogs. Circulation 91: 2982-2988, 1995.